Refer to the technical report entitled “Mineral Resource Estimate Update ... Technical Information and Quality Control & ...

We recently wrote about the complex path of the regulatory pathway in research, getting drugs from the lab bench to pharmacy ...

RKLB's strong revenue growth and market position in aerospace make it a promising investment opportunity with sustained ...

Only half of people with early-onset cancers reported discussing fertility preservation options prior to their oncology ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, ladies and gentlemen, and welcome to Repligen ...

Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

Please go ahead. Thank you, and welcome to our third quarter of 2024 report. On this call, we will cover business highlights and financial performance for the three- and nine-month periods ending ...

Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech reports third quarter 2024 financial results. (Operator Instructions) Please be advised that today's conference is being ...

Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, USA ...

A discussion of the factors that could cause a material difference ... taking place at the company and feedback received from the investment community. For example, this quarter we expanded our public ...